We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$9.47B
AUM Growth
+$600M
(+6.8%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
4.75%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
2,316
New
178
Increased
1,104
Reduced
849
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$39.8M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$38.6M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$29.1M |
| 4 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$25.3M |
| 5 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$24.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Dorsey Wright Focus 5 ETF
FV
|
+$23.2M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.9M |
| 3 |
iShares US Basic Materials ETF
IYM
|
+$18.6M |
| 4 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$16.3M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Financials | 4.7% |
| 3 | Healthcare | 4.16% |
| 4 | Industrials | 3.45% |
| 5 | Consumer Discretionary | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.A
376
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.46M | 0.05% |
64,465
+5,590
| +9% | +$387K |
|
377
WisdomTree Japan Hedged Equity Fund
DXJ
$7.46B
| $4.45M | 0.05% |
82,518
+3,541
| +4% | +$200K |
|
378
Norfolk Southern
NSC
$75.3B
| $4.44M | 0.05% |
29,445
-691
| -2% | -$101K |
|
379
Truist Financial
TFC
$63.5B
| $4.36M | 0.05% |
86,396
-18,785
| -18% | -$998K |
|
380
ProShares Ultra Technology
ROM
$1.28B
| $4.34M | 0.05% |
+337,632
| New | +$4.28M |
|
381
L3Harris
LHX
$53.8B
| $4.33M | 0.05% |
29,944
+2,435
| +9% | +$377K |
|
382
Fidelity MSCI Health Care Index ETF
FHLC
$3.41B
| $4.33M | 0.05% |
104,771
-9,244
| -8% | -$377K |
|
383
Idexx Laboratories
IDXX
$47.1B
| $4.31M | 0.05% |
19,760
+2,494
| +14% | +$514K |
|
384
Enbridge
ENB
$113B
| $4.26M | 0.05% |
119,424
-62,358
| -34% | -$1.97M |
|
385
iShares Silver Trust
SLV
$31.6B
| $4.25M | 0.04% |
280,617
+5,060
| +2% | +$78.8K |
|
386
Clorox
CLX
$13.1B
| $4.24M | 0.04% |
31,365
+4,304
| +16% | +$531K |
|
387
Mondelez International
MDLZ
$78.5B
| $4.21M | 0.04% |
102,592
-9,158
| -8% | -$368K |
|
388
Ecolab
ECL
$80.1B
| $4.2M | 0.04% |
29,933
+84
| +0.3% | +$12.1K |
|
389
iShares US Consumer Discretionary ETF
IYC
$1.23B
| $4.2M | 0.04% |
86,612
-173,448
| -67% | -$8.17M |
|
390
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
| $4.18M | 0.04% |
56,361
+2,712
| +5% | +$196K |
|
391
Monster Beverage
MNST
$88.9B
| $4.14M | 0.04% |
288,728
+3,268
| +1% | +$44.1K |
|
392
Regeneron Pharmaceuticals
REGN
$82.7B
| $4.12M | 0.04% |
11,947
+479
| +4% | +$150K |
|
393
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.2B
| $4.11M | 0.04% |
116,865
+34,063
| +41% | +$1.18M |
|
394
Nuveen Municipal Value Fund
NUV
$1.9B
| $4.1M | 0.04% |
428,411
+9,041
| +2% | +$85.9K |
|
395
Rithm Capital
RITM
$5.71B
| $4.09M | 0.04% |
233,682
+5,624
| +2% | +$98.7K |
|
396
Quest Diagnostics
DGX
$26.3B
| $4.08M | 0.04% |
37,116
-536
| -1% | -$55.8K |
|
397
Applied Materials
AMAT
$423B
| $4.08M | 0.04% |
88,283
-6,721
| -7% | -$346K |
|
398
iShares MSCI United Kingdom ETF
EWU
$4.15B
| $4.03M | 0.04% |
115,907
+22,494
| +24% | +$810K |
|
399
Vanguard Total World Stock ETF
VT
$81.4B
| $4M | 0.04% |
54,559
-19,190
| -26% | -$1.43M |
|
400
Toyota
TM
$225B
| $4M | 0.04% |
31,070
+516
| +2% | +$68K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Cambridge Investment Research Advisors held 2,316 positions worth $9.47B, up 6.8% from $8.87B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $450M of net new capital in Q2 2018, opening 178 new positions and adding to 1,104 existing holdings. Its largest new stake was Invesco S&P 500 Quality ETF: 220,002 shares worth $6.6M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was First Trust Dorsey Wright Focus 5 ETF, an estimated $23.2M trimmed.
- Cambridge Investment Research Advisors's largest Q2 2018 buy was Invesco S&P 500 Quality ETF: 220,002 shares worth $6.6M.
- Cambridge Investment Research Advisors added most to iShares S&P 500 Growth ETF in Q2 2018, an estimated $39.8M increase.
- Cambridge Investment Research Advisors's biggest Q2 2018 reduction was First Trust Dorsey Wright Focus 5 ETF, cutting an estimated $23.2M.
- Cambridge Investment Research Advisors fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $8.51M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $9.47B portfolio in Q2 2018.
- Cambridge Investment Research Advisors opened 178 new positions and closed 119 in Q2 2018.
- Cambridge Investment Research Advisors's portfolio value rose 6.8% quarter-over-quarter to $9.47B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.